Ameriprise’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $357K | Buy |
|
|||||
|
2024
Q4 | $430K | Buy |
|
|||||
|
2024
Q3 | $496K | Sell |
|
|||||
|
2024
Q2 | $788K | Buy |
|
|||||
|
2024
Q1 | $845K | Sell |
|
|||||
|
2023
Q4 | $611K | Buy |
|
|||||
|
2023
Q3 | $427K | Buy |
|
|||||
|
2023
Q2 | $553K | Sell |
|
|||||
|
2023
Q1 | $4M | Buy |
|
|||||
|
2022
Q4 | $4.03M | Sell |
|
|||||
|
2022
Q3 | $8.31M | Sell |
|
|||||
|
2022
Q2 | $11.9M | Buy |
|
|||||
|
2022
Q1 | $9.19M | Buy |
|
|||||
|
2021
Q4 | $10.7M | Buy |
|
|||||
|
2021
Q3 | $9.81M | Buy |
|
|||||
|
2021
Q2 | $745K | Buy |
|
|||||
|
2021
Q1 | $859K | Sell |
|
|||||
|
2020
Q4 | $739K | Sell |
|
|||||
|
2020
Q3 | $1.16M | Sell |
|
|||||
|
2020
Q2 | $1.48M | Buy |
|